Department of Molecular Medicine, University of Padua, Padua, Italy.
Section of Digestive Disease, Liver Center, Yale University, Yale, USA.
Biochim Biophys Acta Mol Basis Dis. 2019 May 1;1865(5):954-964. doi: 10.1016/j.bbadis.2018.07.025. Epub 2018 Aug 11.
Cholestasis is a frequent clinical condition initiating or complicating chronic liver diseases, particularly cholangiopathies, where the biliary epithelium is the primary target of the pathogenetic sequence. Until a few decades ago, understanding of cholestasis relied mostly on the experimental model of bile duct ligation in rodents. However, a simple model of biliary obstruction cannot reproduce the complex mechanisms and networks leading to cholestasis in cholangiopathies. These networks are underpinned by an intricate dysregulation of pro-inflammatory and pro-fibrotic signals involving besides cholangiocytes, multiple cell elements of both innate and adaptive immunity. Therefore, in the last years, a wide range of animal models of biliary injury have been developed, mostly in mice, following three main approaches, chemical induction, immunization and genetic manipulation. In this review, we will give an update of the animal models of the two main cholangiopathies, primary sclerosing cholangitis and primary biliary cholangitis, which have provided us with the most relevant insights into the pathogenesis of these still controversial diseases.
胆汁淤积症是一种常见的临床病症,可引发或加重慢性肝病,尤其是胆管疾病,其中胆管上皮细胞是致病序列的主要靶标。直到几十年前,人们对胆汁淤积症的理解主要依赖于啮齿动物胆管结扎的实验模型。然而,单纯的胆管阻塞模型无法复制导致胆管疾病的复杂机制和网络。这些网络的基础是炎症和纤维化信号的复杂失调,除了胆管细胞,还涉及固有和适应性免疫的多种细胞成分。因此,在过去几年中,已经开发了多种胆汁损伤的动物模型,主要是在小鼠中,采用三种主要方法,化学诱导、免疫和遗传操作。在这篇综述中,我们将更新原发性硬化性胆管炎和原发性胆汁性胆管炎这两种主要胆管疾病的动物模型,这些模型为我们了解这些仍有争议的疾病的发病机制提供了最相关的见解。